Literature DB >> 8419619

Immunoglobulin allotypic markers in Kawasaki disease.

S T Shulman1, M Melish, O Inoue, H Kato, S Tomita.   

Abstract

We investigated the possible relationship of the distribution of immunoglobulin allotypic markers for susceptibility to Kawasaki disease in Japanese, Japanese-American, and white American populations. The kappa-chain allotype Km1 was present in 25.6% of sera from white patients with Kawasaki disease and in 14.4% of control sera (p < 0.01), and the combination of Km1 with Gm heterozygosity was present in 17.9% of white patients with Kawasaki disease and in 6.4% of control sera (p < 0.0001). In all populations studied, differences were observed between the patients with Kawasaki disease and the race-matched control subjects. The findings support the hypothesis that one or more unknown infectious agents may trigger genetically influenced immune responses that result in clinically recognizable Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419619     DOI: 10.1016/s0022-3476(05)83493-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Kawasaki disease in dizygotic twins.

Authors:  K Kaneko; A Unno; M Takagi; T Maruyama; K Obinata
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

2.  The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?

Authors:  A R Porcalla; C A Sable; K M Patel; G R Martin; N Singh
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 3.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

Review 4.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 5.  Advances in Kawasaki disease.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.860

Review 6.  Recent Advances in Kawasaki Disease.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

7.  ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.

Authors:  Kyu Yeun Kim; Yoon Sun Bae; Woohyuk Ji; Dongjik Shin; Ho Seong Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

Review 8.  Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Authors:  Caroline Galeotti; Jagedeesh Bayry; Isabelle Kone-Paut; Srinivas V Kaveri
Journal:  Autoimmun Rev       Date:  2010-01-13       Impact factor: 9.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.